United Therapeutics
UTHR
UTHR
564 hedge funds and large institutions have $14.6B invested in United Therapeutics in 2024 Q2 according to their latest regulatory filings, with 104 funds opening new positions, 200 increasing their positions, 192 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.34% more ownership
Funds ownership: 95.8% → 103.15% (+7.3%)
4% more repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 192
1% more call options, than puts
Call options by funds: $281M | Put options by funds: $279M
Holders
564
Holding in Top 10
18
Calls
$281M
Puts
$279M
Top Buyers
| 1 | +$473M | |
| 2 | +$139M | |
| 3 | +$114M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$109M |
| 5 |
Amundi
Paris,
France
|
+$95.8M |
Top Sellers
| 1 | -$165M | |
| 2 | -$136M | |
| 3 | -$84.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$80.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$71.8M |